<DOC>
	<DOCNO>NCT02018055</DOCNO>
	<brief_summary>The purpose study evaluate efficacy safety clopidogrel stabilize patient acute myocardial infarction ( AMI ) perform percutaneous coronary intervention ( PCI ) drug-eluting stent ( DES ) compare ticagrelor . In study , 3,288 patient AMI underwent PCI DES take dual antiplatelet therapy aspirin ticagrelor 1 month index PCI randomize aspirin ticagrelor versus aspirin clopidogrel 11 month .</brief_summary>
	<brief_title>Compare Efficacy Safety Clopidogrel v Ticagrelor Stabilized Patients With Acute Myocardial Infarction After Percutaneous Coronary Intervention ; TicAgrelor Versus CLOpidogrel Stabilized Patients With Acute Myocardial Infarction : TALOS-AMI</brief_title>
	<detailed_description />
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Clopidogrel</mesh_term>
	<mesh_term>Ticlopidine</mesh_term>
	<mesh_term>Ticagrelor</mesh_term>
	<criteria>1 . Women men , age â‰¥ 18 2 . Patients acute myocardial infarction ( nonSTelevation myocardial infarction STelevation myocardial infarction ) take medicine ticagrelor 30 day undergo percutaneous coronary intervention drugeluting stent 3 . Patients previously give informed consent participation study 4 . Female patient , childbearing potential commit use adequate contraception 1 . Cardiogenic shock 2 . Acitve internal bleeding , history bleeding diathesis , coagulopathy 3 . Gastrointestinal bleeding , genitourinary bleeding , hemoptysis , vitreoretinal bleeding 4 . Major surgery within 6 week prior screen 5 . Intracranial bleed structural abnormality 6 . Anemia ( hemoglobin &lt; 10 g/dL ) time screen Platelet count le 100,000/mm3 time screen 7 . Oral anticoagulation safely discontinue duration study 8 . Daily treatment nonsteroidal antiinflammatory drug clooxygenase2 inhibitor 9 . Malignancy life expectancy &lt; 1 10 . Known severe hepatic dysfunction 11 . Symptomatic patient sinus bradycardia atrioventricular block 12 . Symptomatic patient chronic obstructive pulmonary disease 13 . Intolerance allergy aspirin , ticagrelor , clopidogrel 14 . Treatment within 3 month investigational drug presently enrol another drug device study ( except registry observational study ) 15 . Women know pregnant , give birth within past 90 , breastfeed 16 . Patients perform kidney transplantation require dialysis 17 . A patient genetic disorder ; example galactose intolerance , Lapp lactase deficiency glucose galactose malabsorption . 18 . Any condition may put patient risk influence study result investigator ' opinion</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2015</verification_date>
</DOC>